CLRB - 3.03 Pre-market now at 3.25/3.35. Cellectar Biosciences Announces Lead Compound CLR 131 To Be Studied In Head and Neck Cancer in $12M University of Wisconsin SPORE Grant http://stockcharts.com/c-sc/sc?s=CLRB&p=D&b=5&g=0&i=t66152161614&r=1473683986949 http://stockcharts.com/c-sc/sc?s=CLRB&p=W&b=5&g=0&i=t50998454352&r=1473684013409